Access Resources
271 - 280 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Functional Brain Networks to Evaluate Treatment Responses in Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 1653End Page: 1668Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-023-01433-wCitation Count: 0
-
RESTRICTEDTitle: Genome-wide Analysis of Motor Progression in Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200092Best OA location URL: https://ng.neurology.org/content/nng/9/5/e200092.full.pdfCitation Count: 3
-
RESTRICTEDTitle: Impaired pre-synaptic plasticity and visual responses in auxilin-knockout miceJournal Name: iSciencePublisher: Elsevier BVVol: 26Issue #: 10Start Page: 107842End Page: 107842Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2023.107842Best OA location URL: https://doi.org/10.1016/j.isci.2023.107842Citation Count: 0
- Neuron-derived extracellular vesicles to examine brain mTOR target engagement with sirolimus in patients with multiple system atrophy2023RESTRICTEDTitle: Neuron-derived extracellular vesicles to examine brain mTOR target engagement with sirolimus in patients with multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 115Issue #:Start Page: 105821End Page: 105821Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105821Citation Count: 0
- Parallel neurodegenerative phenotypes in sporadic Parkinson’s disease fibroblasts and midbrain dopamine neurons2023RESTRICTEDTitle: Parallel neurodegenerative phenotypes in sporadic Parkinson’s disease fibroblasts and midbrain dopamine neuronsJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 229Issue #:Start Page: 102501End Page: 102501Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102501Best OA location URL: https://doi.org/10.1016/j.pneurobio.2023.102501Citation Count: 1
- Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy2023RESTRICTEDTitle: Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 187Issue #:Start Page: 106287End Page: 106287Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106287Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106287Citation Count: 0
- Simulations predict differing phase responses to excitation vs. inhibition in theta-resonant pyramidal neurons2023RESTRICTEDTitle: Simulations predict differing phase responses to excitation vs. inhibition in theta-resonant pyramidal neuronsJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 130Issue #: 4Start Page: 910End Page: 924Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1152/jn.00160.2023Best OA location URL: https://doi.org/10.1152/jn.00160.2023Citation Count: 1
-
RESTRICTEDTitle: Targeting LRRK2 mRNA stability in Parkinson’s diseaseJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tins.2023.10.003Citation Count: 0
-
RESTRICTEDTitle: The importance of a healthy mouth in Parkinson's diseaseJournal Name: The LancetPublisher: Elsevier BVVol: 402Issue #: 10411Start Page: 1419End Page: 1420Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(23)01466-6Best OA location URL: http://www.thelancet.com/article/S0140673623014666/pdfCitation Count: 1
- Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop2023RESTRICTEDTitle: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area WorkshopJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 1682End Page: 1691Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-023-01440-xBest OA location URL: https://doi.org/10.1007/s13311-023-01440-xCitation Count: 1